药物警戒

Pharmacovigilance is an essential component of drug regulation, ensuring the continuous monitoring of the safety profile of medicines once they're marketed.
药物警戒是药品监管的重要组成部分，负责确保药物上市后对其安全性状况进行持续监测。
The role of pharmacovigilance is to detect, assess, understand and prevent adverse effects or any other drug-related problems.
药物警戒的作用在于检测、评估、理解和预防不良反应或任何其他与药物相关的难题。
Through active pharmacovigilance, we can promptly identify signals that may indicate potential risks associated with a medicine.
通过主动药物警戒，我们可以及时发现可能表明药物存在潜在风险的信号。
Post-marketing pharmacovigilance activities include spontaneous reporting systems for adverse drug reactions and periodic safety update reports.
上市后药物警戒活动包括对药品不良反应的自发报告系统以及定期的安全更新报告。
A robust pharmacovigilance system helps healthcare professionals make informed decisions about the benefits and risks of using specific medications.
一个健全的药物警戒系统有助于医疗保健专业人员就使用特定药物的利弊做出知情决策。
Patient reporting is encouraged in pharmacovigilance as it provides valuable insights into real-world experiences with medicines.
药物警戒鼓励患者报告，因为它能为药物在真实世界中的应用提供宝贵的见解。
The implementation of a global pharmacovigilance database allows for international collaboration on drug safety issues.
全球药物警戒数据库的实施使得国际间能够针对药物安全问题展开合作。
Effective pharmacovigilance necessitates timely communication between pharmaceutical companies, regulatory agencies, and healthcare providers.
有效的药物警戒需要制药公司、监管机构和医疗服务提供者之间及时沟通。
Risk management plans are integral parts of pharmacovigilance, outlining strategies to minimize risks associated with a particular medicinal product.
风险管理计划是药物警戒不可或缺的部分，它概述了降低特定药品相关风险的策略。
The World Health Organization (WHO) plays a critical role in coordinating international pharmacovigilance activities and establishing global standards.
世界卫生组织（WHO）在协调国际药物警戒活动和制定全球标准方面发挥着关键作用。